Research and Development

Our mission is centered around improving health and bringing innovative treatments to patients around the globe. Our R&D efforts are focused on discovering, developing and delivering life-transforming medicines for rare and more prevalent diseases across three areas: Oncology, Neuroscience and Gastrointestinal and Inflammation. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. By embedding data, digital and technology across research and development, we will deliver our new medicines to patients faster.

Discover more about our focus areas, products and patient services that reflect our unwavering dedication to better health for individuals worldwide.

Our Global Areas of Focus

Oncology

Seeking novel medicines for patients with cancer worldwide

Rare Diseases

Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders

Neuroscience

Driving medical innovation for patients with neurologic and psychiatric diseases

Gastroenterology

Focusing on understanding, treating and reducing impact for those with GI and liver diseases

Plasma-derived therapies

Developing critical andlife-saving medicines for those with rare and complex diseases

Vaccines

Addressing unmet medical needs through vaccine development against infectious diseases

Explore

Independent Medical Education Grants

Takeda and its Alliance partners are committed to supporting high-quality, un-biased, evidence-based independent medical education for healthcare professionals, teams, patients, payers and systems.

FIND OUT MORE

Patient Services

Patients are at the heart of everything we do. Our U.S. Patient Services programs provide product support that is driven by specialists dedicated to a single goal: providing patients and caregivers with caring, comprehensive support across our many therapeutic areas and products.

FIND OUT MORE

Products

Committed to better health for individuals, Takeda in the U.S. markets innovative pharmaceutical treatments.

FIND OUT MORE

Research and Development | United States